Seismic Therapeutics
Immunology therapeutics company using machine learning and protein engineering to transform autoimmune disease treatment by developing next-generation immunomodulatory therapies.
Notes
Seismic Therapeutics is an immunology-focused biotechnology company using machine learning and protein engineering to develop next-generation therapeutics for autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Seismic's approach combines computational biology and AI-driven protein design with traditional drug development to create novel immunomodulatory therapies. The company aims to transform the treatment of autoimmune diseases by developing more targeted and effective therapies with improved safety profiles.
The company is backed by Polaris Partners, a leading healthcare-focused venture capital firm.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Portfolio company of Polaris Partners
- Focus on AI-driven immunology therapeutics
- Machine learning and protein engineering approach
- Autoimmune disease focus
- Cambridge, Massachusetts headquarters
- Founded in 2021
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |